Literature DB >> 7063671

Arterioportal communications: observations and hypotheses concerning transsinusoidal and transvasal types.

J J Bookstein, K J Cho, G B Davis, D Dail.   

Abstract

Arterioportal shunting is observed angiographically in a wide variety of pathologic conditions. The route of flow has classically been considered to be via the hepatic sinusoids (transsinusoidal). This route occurs in cases of cirrhosis or the Budd-Chiari syndrome, and results in retrograde hepatofugal flow in portal branches. More recently, a transvasal route has been recognized angiographically, in which portal flow often remains hepatopetal. The transvasal route occurs in cases of hepatocellular carcinoma, metastases, shock, hepatic arterial obstruction, and many other conditions. Histologic confirmation of this route has been sought for many years, with other partial success. Nevertheless, angiographic evidence, as presented here, is sufficiently compelling to justify description of this pathway and its significance. Arterioportal flow may also occur via a post-traumatic fistula (disruption of adjacent portions of hepatic artery and portal vein), and via benign tumor vessels in hemangioma or hemangioendothelioma.

Entities:  

Mesh:

Year:  1982        PMID: 7063671     DOI: 10.1148/radiology.142.3.7063671

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

1.  Qualitative and quantitative analysis of portal Doppler waveform and a novel factor of portal pulsatility: Systolic spike wave.

Authors:  Hiroyuki Sugimoto; Tetsuya Kaneko Fjsum; Tsuyoshi Hatsuno; Shin Takeda; Soichiro Inoue; Akimasa Nakao
Journal:  J Med Ultrason (2001)       Date:  2002-09       Impact factor: 1.314

2.  Echo-Doppler evaluation of reverse flow sign in the intrahepatic portal branches after surgery.

Authors:  K Nishihara; T Yagyu; K Sakata; K Nakashima; T Suzuki
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

3.  Portal Vein Thrombosis and Arterioportal Fistula in Post Liver Transplant Recipient: A Case Report.

Authors:  Shruti P Gandhi; Kajal Patel; Vaibhav Sutariya; Pranjal Modi
Journal:  J Clin Diagn Res       Date:  2016-09-01

4.  Infantile hemangioendothelioma: angiographic features and factors determining efficacy of hepatic artery embolization.

Authors:  D R Burke; A Verstandig; O Edwards; S G Meranze; G K McLean; E J Stein
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

5.  Liver microcirculation after hepatic artery embolization with degradable starch microspheres in vivo.

Authors:  Jian Wang; Satoru Murata; Tatsuo Kumazaki
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

6.  Vascular invasion by hepatocellular carcinoma.

Authors:  B I Choi
Journal:  Abdom Imaging       Date:  1995 May-Jun

Review 7.  Hepatic arterioportal shunts: dynamic CT and MR features.

Authors:  Byung Ihn Choi; Kyoung Ho Lee; Joon Koo Han; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2002 Jan-Mar       Impact factor: 3.500

8.  Atypically enhanced cavernous hemangiomas of the liver: centrifugal enhancement does not preclude the diagnosis of hepatic hemangioma.

Authors:  Masahiro Matsushita; Yasuo Takehara; Hatsuko Nasu; Yuki Hirai; Shuhei Yamashita; Kenichi Souda; Yoshimasa Kobayashi; Katsutoshi Miura
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

9.  High lung shunt fraction in colorectal liver tumors is associated with distant metastasis and decreased survival.

Authors:  Amy R Deipolyi; A John Iafrate; Andrew X Zhu; Emel A Ergul; Suvranu Ganguli; Rahmi Oklu
Journal:  J Vasc Interv Radiol       Date:  2014-07-30       Impact factor: 3.464

10.  Intraarterial digital subtraction angiography with carbon dioxide: superior detectability of arteriovenous shunting.

Authors:  T Takeda; K Ido; Y Yuasa; G Nishimura; S Hashimoto; E Kyo; S Okawa; S Nakatsuka; H Miura; S Kobayashi
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.